设为首页
收藏本站
首页
个人简介
名医风采
学术思想
学术成就
学术著作
中文论文
SCI论文
科研奖项
典型案例
不育症
尿路结石
慢性肾衰
慢性肾炎
泌尿系感染
其他肾病
痛风
肾虚
医疗机构制剂
最新动态
学科动态
媒体动态
1
2
学术成就
学术著作
中文论文
SCI论文
科研奖项
学术思想
一.肾病多虚、阴虚多见
二.食饮有节、不妄劳作
三.未病先防、炼液为膏
四.内病外治、简便效廉
五.师古不泥、活用经方
六.病证结合、善治结石
友情链接
湖北省中医院
湖北省中医院肾病科
学术成就
当前位置：
首页
>
学术成就
邵朝弟治疗过敏性紫癜肾炎验案举隅
梅国强运用四土汤治疗紫癜验案2则
从肾论治人流术后月经过少的探讨
邵朝弟教授运用大黄治疗慢性肾衰竭的临床思辨经验
大黄治疗慢性肾衰竭临床应用及炮制研究
补肾祛邪法对HBeAg阴性慢性乙型肝炎患者肝纤维化及相关血清细胞因子的影响
高频彩超观察天楼解毒消肿散治疗大鼠糖尿病足的疗效
湖北省人民政府科学技术进步壹等奖，2024年基于治未病思想清肺达原颗粒等防治COVID-19的研究与应用。
武汉中医大师
发明专利：一种治疗慢性肾脏病3期的中药制剂及其制备方法
Jingtian granule alleviates adenine-induced renal fibrosis in mice through SIRT3-Mediated deacetylation of P53.
Exploration of the utility of different doses of Qingfei Dayuan granules: a multicenter, randomized, double-blind, placebo-controlled trial
Effectiveness of Xiangsha Liujun pills on decreased digestive function in convalescent patients of coronavirus disease 2019: a randomized, double blind, placebo controlled clinical trial
Effectiveness of Xiaoyao capsule on sleep disorders and mood disturbance in patients in recovery from coronavirus disease 2019: a randomized controlled trial
Effectiveness and safety of Qingfei Dayuan granules for treating influenza and upper respiratory tract infections manifested by the pulmonary heat-toxin syndrome: A multicenter, randomized, double-blind, placebo-controlled trial
Emodin ameliorates renal injury and fibrosis via regulating the miR-490-3p/HMGA2 axis
Effectiveness and safety of Jinshuibao capsules in treatment of residual cardiopulmonary symptoms in convalescent patients of coronavirus disease 2019: a pilot randomized, double-blind, placebo-controlled clinical trial
Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trial
Uric acid as a prognostic factor and critical marker of COVID-19
Relationship between the dynamic changes of serum 2019-nCoV IgM/IgG and patient immunity after 6 month hospital discharge
首页
上页
2
3
4
5
6
7
8
9
10
下页
尾页
X 关闭
预约挂号操作流程
